Study for Perioperative Neurocognitive Disorders After Deep Brain Stimulation Surgery for Parkinson's Disease
NCT04696978 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2021-01-06
Summary
Perioperative neurocognitive disorders(PND) is common to see in elderly patients. Although PND increases patient mortality as well as hospitalization time, apparent inflammatory factors, and related mechanisms are still unknown. Metabolites could reveal chemical fingerprints left behind by cellular processes, which in turn provide a new aspect to understand the biological process behind. we aim to found the metabolomics can aid the development of diagnostic markers of PND screening, early detection, and further, provide a basis for disease prevention and treatment.
Conditions
- Neurocognitive Disorders
Sponsors & Collaborators
-
wenbinlu
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-08-01
- Primary Completion
- 2022-08-01
- Completion
- 2022-12-01
Countries
- China
Study Locations
More Related Trials
-
Deep Brain Stimulation in Patients With Parkinson's Disease
NCT00586079 ·Status: COMPLETED ·Phase: NA
-
CS1P1 PET Studies of Neuroinflammation in Parkinson Disease
NCT06084533 ·Status: ENROLLING_BY_INVITATION
-
Neural Correlates of Cognition in Parkinson's Disease
NCT02975193 ·Status: COMPLETED ·Phase: NA
-
The National Registry Study For the Real-world Patients With Parkinsonian Disorders in China
NCT03649503 ·Status: RECRUITING
-
Relationship of Dopamine to Cognitive Function in Parkinson's Disease
NCT00094601 ·Status: COMPLETED
-
NMR Based Metabolomic Study of Serum Biomarkers in Patients With Parkinson's Disease and Atypical Parkinsonian Syndrome
NCT06490926 ·Status: RECRUITING
-
Neuroplasticity in Parkinson's Disease
NCT05286736 ·Status: RECRUITING
-
Effect of Deep Brain Stimulation on Depression and Quality of Life in Parkinson's Patients
NCT00179101 ·Status: COMPLETED
-
Cognitive Decline Following Deep Brain Stimulation
NCT05822388 ·Status: RECRUITING
-
Deep Brain Stimulation on Dual-task Gait Performance in PD
NCT05314322 ·Status: UNKNOWN ·Phase: NA
-
A Follow-up of the Influencing Factors of Dyskinesia in Patients With Parkinson's Disease
NCT04453995 ·Status: UNKNOWN
-
Follow Up Study for Treatment of Parkinson's Disease With Deep Brain Stimulation
NCT01022073 ·Status: COMPLETED
-
Study on Serum Cystatin C and PET-DAT in Patients With Parkinson's Disease
NCT04926909 ·Status: UNKNOWN
-
Research Involving Subjects With Parkinson's Disease, Alzheimer Disease and Healthy Controls
NCT01461109 ·Status: COMPLETED ·Phase: PHASE1
-
Cognitive Decline Following Deep Brain Stimulation: A DBS-fMRI Study
NCT06960096 ·Status: RECRUITING
-
Efficacy of Continuous Apomorphine Infusion on Cognitive and Neuropsychological Functions in Parkinson's Disease
NCT01039090 ·Status: COMPLETED ·Phase: PHASE3
-
Individual Neuromodulation for PDS
NCT06193278 ·Status: UNKNOWN ·Phase: NA
-
Asleep Versus Awake Deep Brain Stimulation Surgery
NCT02424929 ·Status: COMPLETED ·Phase: NA
-
Measures of Mitochondria Dysfunction in PD
NCT04300608 ·Status: UNKNOWN
-
Neurophysiology Biomarkers of Cognitive Impairment Associated With Deep Brain Stimulation
NCT05933681 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Serum Biomarkers in Parkinson's Disease at Different Stages
NCT05769699 ·Status: RECRUITING ·Phase: NA
-
Identification of a Biomarker Predictive of Evolution of Parkinson Disease
NCT03230526 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Dopaminergic Mechanism of Memory Impairment in Parkinson's Disease
NCT04968613 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of Motor Function, Depression and Sleep Quality on Attention in Parkinson's Disease
NCT06283043 ·Status: ENROLLING_BY_INVITATION
-
Clinical Correlates of COVID-19 Pandemic in Patients With Functional Movement Disorder (FMD) and Parkinson's Disease (PD)
NCT04565080 ·Status: COMPLETED